← FDA Drug Approvals (Drugs@FDA)

FOSAPREPITANT DIMEGLUMINE

NDA · New Drug Application · Sponsor: TEVA PHARMS USA · Approved 2019-09-05

Drug application

FDA Application #

NDA210064

Application type

New Drug Application

Brand name

FOSAPREPITANT DIMEGLUMINE

Generic name

FOSAPREPITANT

Active ingredients

FOSAPREPITANT DIMEGLUMINE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

TEVA PHARMS USA

Manufacturer

Actavis Pharma, Inc.

First approval

2019-09-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown